Boao Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Boao Xie has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Cong Zhang
Department of Vascular and Endovascular Surgery, First Affiliated Hospital of Zhengzhou University, Henan 450052, China
2 shared publications- Hualong Bai
Department of Vascular and Endovascular Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
2 shared publications - Shunbo Wei
Department of Vascular and Endovascular Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China
2 shared publications Wang Wang
Department of Physiology, Medical School of Zhengzhou University, Henan 450001, China
2 shared publications- Chenxuan Wang
State Key Laboratory of Common Mechanism Research for Major Diseases Department of Biophysics and Structural Biology Institute of Basic Medical Sciences & School of Basic Medicine Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China
1 shared publication Haoliang Wu
Department of Vascular and Endovascular Surgery, First Affiliated Hospital of Zhengzhou University, Henan 450052, China
1 shared publication
Latest Publications
- 17 September 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (38) , e71726
Stabilizing and Programming Gallium in Hydrogels: From Iron‐Mimetic Bioactivity to Localized Therapeutic Function
Gallium (Ga) is an iron‐mimetic metal with broad‐spectrum antimicrobial activity and emerging potential in bone regeneration and localized cancer therapy. However, its biomedical translation is limited by unfavorable pharmacokinetics, systemic exposure, and hydrolytic instability of free Ga 3 + under physiological conditions. Hydrogels offer a versatile strategy by stabilizing gallium species, enhancing local retention, regulating release, and providing tissue‐compatible interfaces and microenvironmental modulation. This review focuses on how hydrogel design can stabilize different gallium species, control their local availability, and improve therapeutic performance across distinct pathological microenvironments. We summarize gallium bioactivity and speciation, classify gallium‐containing hydrogels according to gallium incorporation and network interactions, and analyze how network architecture, coordination chemistry, degradation, and external stimuli govern retention and release. Emerging applications include infected wound and biofilm treatment, bone repair, localized cancer therapy, and other site‐specific interventions. We further discuss iron competition, immune regulation, cytotoxicity, liquid‐metal stability, and translational barriers, and outline directions for mechanism‐guided and quantitatively standardized gallium‐hydrogel design.
- 17 September 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (38) , e71726
Stabilizing and Programming Gallium in Hydrogels: From Iron‐Mimetic Bioactivity to Localized Therapeutic Function
Gallium (Ga) is an iron‐mimetic metal with broad‐spectrum antimicrobial activity and emerging potential in bone regeneration and localized cancer therapy. However, its biomedical translation is limited by unfavorable pharmacokinetics, systemic exposure, and hydrolytic instability of free Ga 3 + under physiological conditions. Hydrogels offer a versatile strategy by stabilizing gallium species, enhancing local retention, regulating release, and providing tissue‐compatible interfaces and microenvironmental modulation. This review focuses on how hydrogel design can stabilize different gallium species, control their local availability, and improve therapeutic performance across distinct pathological microenvironments. We summarize gallium bioactivity and speciation, classify gallium‐containing hydrogels according to gallium incorporation and network interactions, and analyze how network architecture, coordination chemistry, degradation, and external stimuli govern retention and release. Emerging applications include infected wound and biofilm treatment, bone repair, localized cancer therapy, and other site‐specific interventions. We further discuss iron competition, immune regulation, cytotoxicity, liquid‐metal stability, and translational barriers, and outline directions for mechanism‐guided and quantitatively standardized gallium‐hydrogel design.
- 17 March 2022
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 5 (4) , 1501-1507
PLGA Nanoparticle Rapamycin- or Necrostatin-1-Coated Sutures Inhibit Inflammatory Reactions after Arterial Closure in Rats
Background: The inflammatory reaction of sutures and oozing after arterial closure depends on the suture material and the amount of oozing surrounding the sutures. Anti-inflammation coatings have been proven to be an effective strategy to decrease this reaction. The aim of this study was to establish an arterial closure oozing model in rats and to test the effect of poly (lactic-co-glycolic acid) (PLGA) nanoparticle (NP) rapamycin- or necrostatin-1(NEC-1)-coated sutures on the inflammatory reaction after arterial closure. Methods and Materials: A 10 mm arteriotomy was carried out on the carotid artery of Sprague–Dawley rats and closed using 11-0 sutures. PLGA NP-rapamycin and NEC-1 were made. The 11/0 nylon sutures were coated with PLGA NP-rapamycin and NEC-1. Sutures were examined by scanning electron microscopy, hemolysis test, and cumulative release. The carotid arteriotomy was closed using uncoated PLGA NP-rapamycin- and NP-NEC-1-coated sutures. The carotid artery was harvested on day 7. Tissues were examined by histology and immunohistochemistry. Results: There were severe inflammatory reactions in the oozing arteries compared to the normal healing arteries (P = 0.0192). PLGA NP-rapamycin- and NEC -1-coated sutures reduced foreign body reaction compared to the uncoated sutures. There were significantly smaller number of CD3 (P = 0.0068), CD45 (P = 0.0300), and CD68 (P = 0.0011) cells in the PLGA NP-rapamycin- and NP-NEC-1-coated groups compared to the uncoated group. There was a smaller number of p-mTOR (P = 0.0198)-positive cells in the PLGA NP-rapamycin-coated group compared to the uncoated group. There was a smaller number of TNFα (P = 0.0198)-positive cells in the PLGA NP-NEC-1-coated group compared to the uncoated group. Conclusions: In this rat carotid artery oozing model, PLGA NP-rapamycin- or NP-NEC-1-coated sutures can inhibit inflammatory reaction and foreign body reaction. Although this was a small rodent animal experiment, this coated suture may have a potential clinical application in the future.
- 17 March 2022
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 5 (4) , 1501-1507
PLGA Nanoparticle Rapamycin- or Necrostatin-1-Coated Sutures Inhibit Inflammatory Reactions after Arterial Closure in Rats
Background: The inflammatory reaction of sutures and oozing after arterial closure depends on the suture material and the amount of oozing surrounding the sutures. Anti-inflammation coatings have been proven to be an effective strategy to decrease this reaction. The aim of this study was to establish an arterial closure oozing model in rats and to test the effect of poly (lactic-co-glycolic acid) (PLGA) nanoparticle (NP) rapamycin- or necrostatin-1(NEC-1)-coated sutures on the inflammatory reaction after arterial closure. Methods and Materials: A 10 mm arteriotomy was carried out on the carotid artery of Sprague–Dawley rats and closed using 11-0 sutures. PLGA NP-rapamycin and NEC-1 were made. The 11/0 nylon sutures were coated with PLGA NP-rapamycin and NEC-1. Sutures were examined by scanning electron microscopy, hemolysis test, and cumulative release. The carotid arteriotomy was closed using uncoated PLGA NP-rapamycin- and NP-NEC-1-coated sutures. The carotid artery was harvested on day 7. Tissues were examined by histology and immunohistochemistry. Results: There were severe inflammatory reactions in the oozing arteries compared to the normal healing arteries (P = 0.0192). PLGA NP-rapamycin- and NEC -1-coated sutures reduced foreign body reaction compared to the uncoated sutures. There were significantly smaller number of CD3 (P = 0.0068), CD45 (P = 0.0300), and CD68 (P = 0.0011) cells in the PLGA NP-rapamycin- and NP-NEC-1-coated groups compared to the uncoated group. There was a smaller number of p-mTOR (P = 0.0198)-positive cells in the PLGA NP-rapamycin-coated group compared to the uncoated group. There was a smaller number of TNFα (P = 0.0198)-positive cells in the PLGA NP-NEC-1-coated group compared to the uncoated group. Conclusions: In this rat carotid artery oozing model, PLGA NP-rapamycin- or NP-NEC-1-coated sutures can inhibit inflammatory reaction and foreign body reaction. Although this was a small rodent animal experiment, this coated suture may have a potential clinical application in the future.
- Open Access
- 28 September 2021
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 6 (40) , 26715-26721
Biomimetic Elastin Fiber Patch in Rat Aorta Angioplasty
- 28 September 2021
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 6 (40) , 26715-26721
Open AccessBiomimetic Elastin Fiber Patch in Rat Aorta Angioplasty